GeoNova Capital has committed US$10 million as lead investor and corporate adviser to NovaGen Group B.V., following NovaGen's September 14 announcement of a proposed business combination with Nasdaq-listed Veea Inc. The companies have signed a non-binding term sheet and are targeting definitive documentation in the coming weeks. The proposed transaction would create NovaGen Health Networks, a Nasdaq-listed longevity and precision-health platform combining Veea's cybersecure AI infrastructure with NovaGen's cellular-reprogramming science and clinical capabilities. The financing and combination remain subject to definitive documentation, applicable approvals and customary closing conditions. GeoNova said it is seeking co-investors and reviewing additional opportunities involving U.S. public-market transactions across several sectors.